Schering-Plough Corp. is pursuing patent infringement actions against companies seeking approval of generic versions of Clarinex Tablets, Clarinex Reditabs and Clarinex D12.
The Company filed these actions in September 2006. (Lloyds…
Settlement discussions between Johnson & Johnson’s subsidiary, Ortho Women’s Health & Urology, and Barr Laboratories, Inc. regarding the ORTHO TRICYCLEN(R) LO patent are still underway.
Ortho Women’s is a Division of…
The U.S. District Court for the District of California is considering the appropriate remedy for future infringement of Boston Scientific Corporation’s the Kastenhofer patent, according to Johnson & Johnson’s quarterly…
Cordis Corp.’s appeal to the U.S. Court of Appeals for the Federal Circuit from the CYPHER(R) stent patent dispute with Boston Scientific Corporation remains pending.
Cordis is a Johnson & Johnson…
Angiotech Pharmaceuticals Inc. announced on July 10, 2008, that the highest court of the United Kingdom, the House of Lords, confirmed the validity of one of the Company’s patents related…
Dr. Gregory W. Baran’s suit against Medical Device Technologies Inc. for the infringement of U.S. Patent Nos. 5,025,797 and 5,400,798 is in the discovery phase.
Medical Device Technologies is a…
The judgment of the Dutch Court of Appeal on Sahajanand Medical Technologies Pvt. Ltd.’s appeal over the ruling in favor of Angiotech Pharmaceuticals Inc.’s European Patent No. 0706376 is expected…